United Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
CEOMartine A. Rothblatt
CEOMartine A. Rothblatt
Employees1,305
Employees1,305
HeadquartersSilver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded1996
Founded1996
Employees1,305
Employees1,305
UTHR Key Statistics
Market cap13.28B
Market cap13.28B
Price-Earnings ratio11.75
Price-Earnings ratio11.75
Dividend yield—
Dividend yield—
Average volume523.76K
Average volume523.76K
High today$298.30
High today$298.30
Low today$291.13
Low today$291.13
Open price$295.66
Open price$295.66
Volume281.79K
Volume281.79K
52 Week high$417.82
52 Week high$417.82
52 Week low$266.98
52 Week low$266.98
UTHR News
Simply Wall St 2d
United Therapeutics' five-year earnings growth trails the splendid shareholder returnsWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on the bright side, if you b...
Analyst ratings
63%
of 16 ratingsBuy
62.5%
Hold
37.5%
Sell
0%
People also own
Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.